Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
| Molecular Weight | 427.4 g/mol |
|---|---|
| Molecular Formula | C20H21N5O6 |
| XLogP3 | 0.2 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 9 |
| Exact Mass | 427.14918341 g/mol |
| Monoisotopic Mass | 427.14918341 g/mol |
| Topological Polar Surface Area | 187 A^2 |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 748 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 2 | |
|---|---|
| Drug Name | Alimta |
| PubMed Health | Pemetrexed (Injection) |
| Drug Classes | Antineoplastic Agent |
| Drug Label | Pemetrexed disodium heptahydrate has the chemical name L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-, disodium salt, heptahydrate. It is a white to almost-white solid with a molecular formula of C... |
| Active Ingredient | Pemetrexed; Pemetrexed disodium |
| Dosage Form | Injectable |
| Route | injection; Iv (infusion) |
| Strength | eq 500mg base/vial; 500mg; eq 100mg base/vial |
| Market Status | Prescription |
| Company | Lilly |
| 2 of 2 | |
|---|---|
| Drug Name | Alimta |
| PubMed Health | Pemetrexed (Injection) |
| Drug Classes | Antineoplastic Agent |
| Drug Label | Pemetrexed disodium heptahydrate has the chemical name L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-, disodium salt, heptahydrate. It is a white to almost-white solid with a molecular formula of C... |
| Active Ingredient | Pemetrexed; Pemetrexed disodium |
| Dosage Form | Injectable |
| Route | injection; Iv (infusion) |
| Strength | eq 500mg base/vial; 500mg; eq 100mg base/vial |
| Market Status | Prescription |
| Company | Lilly |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
66
PharmaCompass offers a list of Pemetrexed API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pemetrexed manufacturer or Pemetrexed supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pemetrexed manufacturer or Pemetrexed supplier.
PharmaCompass also assists you with knowing the Pemetrexed API Price utilized in the formulation of products. Pemetrexed API Price is not always fixed or binding as the Pemetrexed Price is obtained through a variety of data sources. The Pemetrexed Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CID394493 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CID394493, including repackagers and relabelers. The FDA regulates CID394493 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CID394493 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CID394493 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CID394493 supplier is an individual or a company that provides CID394493 active pharmaceutical ingredient (API) or CID394493 finished formulations upon request. The CID394493 suppliers may include CID394493 API manufacturers, exporters, distributors and traders.
click here to find a list of CID394493 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A CID394493 DMF (Drug Master File) is a document detailing the whole manufacturing process of CID394493 active pharmaceutical ingredient (API) in detail. Different forms of CID394493 DMFs exist exist since differing nations have different regulations, such as CID394493 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A CID394493 DMF submitted to regulatory agencies in the US is known as a USDMF. CID394493 USDMF includes data on CID394493's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The CID394493 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of CID394493 suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing CID394493 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for CID394493 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture CID394493 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain CID394493 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a CID394493 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of CID394493 suppliers with NDC on PharmaCompass.
CID394493 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CID394493 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CID394493 GMP manufacturer or CID394493 GMP API supplier for your needs.
A CID394493 CoA (Certificate of Analysis) is a formal document that attests to CID394493's compliance with CID394493 specifications and serves as a tool for batch-level quality control.
CID394493 CoA mostly includes findings from lab analyses of a specific batch. For each CID394493 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CID394493 may be tested according to a variety of international standards, such as European Pharmacopoeia (CID394493 EP), CID394493 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CID394493 USP).
